Ibrutinib Impurity 30 | CAS 2052279-49-7 - Request Quote
Ibrutinib Impurity 30
| SZ CAT No: | SZ-I005049 |
| CAS No | 2052279-49-7 |
| Mol.F. | C25H24N6O3 |
| Mol.Wt. | 456.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ibrutinib Impurity 30 is chemically (R)-1-(1-Acryloylpiperidin-3-yl)-4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidine 7-oxide. Ibrutinib Impurity 30 is supplied with detailed characterization data compliant with regulatory guideline. Ibrutinib Impurity 30 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ibrutinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2052279-49-7
Purchase 2052279-49-7
Order 2052279-49-7
Enquire 2052279-49-7
price of 2052279-49-7
2052279-49-7 Supplier
2052279-49-7 Manufacturer
2052279-49-7 Exporter
buy high quality Ibrutinib Impurity 30
Purchase Ibrutinib Impurity 30
Ibrutinib Impurity 30 suppliers
Ibrutinib Impurity 30 manufacturers
Ibrutinib Impurity 30 price
Order Ibrutinib Impurity 30
Enquire Ibrutinib Impurity 30
Ibrutinib Impurity 30 cost
Ibrutinib Impurity 30 Supplier
Ibrutinib Impurity 30 Distributor
Ibrutinib Impurity 30 for Method Validation
Ibrutinib Reference Standard
Ibrutinib Impurity 30 for ANDA Filing
Ibrutinib Impurity 30 for Forced Degradation Studies
Ibrutinib Impurity 30 Identification Standards
Ibrutinib Impurity 30 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.